International
Albania
Bosnia and Herzegovina
Bulgaria
Croatia
Czechia
Estonia
Hungary
Latvia
Lithuania
Kosovo
North Macedonia
Poland
Romania
Serbia
Slovakia
Slovenia
Switzerland (German)
Switzerland (French)
Business Development
Media
Cunoaște-ne
Cariere
Contact
PORTOFOLIUL NOSTRU
Medicamente cu prescripție medicală
Medicamente fără prescripție medicală
Parteneri & Mărci comerciale
TESTIMONIALE
Despre Ewopharma
Viziune & Misiune
Valorile Noastre
Strategia Noastră
Management
Responsabilitate Corporativă
Arie de Acoperire
Business Development
Media
Cunoaște-ne
Cariere
Contact
International
Albania
Bosnia and Herzegovina
Bulgaria
Croatia
Czechia
Estonia
Hungary
Latvia
Lithuania
Kosovo
North Macedonia
Poland
Romania
Serbia
Slovakia
Slovenia
Switzerland (German)
Switzerland (French)
Media
COMUNICATE DE PRESĂ
1
2
3
4
Următorul
07.07.2026
Ewopharma and Protina – Strengthening the Presence of Diasporal and Basica in Bulgaria with a new partnership
Citește mai mult
29.05.2026
Ewopharma and Dr. Falk Pharma renew their long-standing partnership - a commitment built to last
Citește mai mult
15.04.2026
Sugemalimab Receives I, A Recommendation in ESMO Guideline for Consolidation Therapy in Patients with Stage Ⅲ NSCLC
Citește mai mult
26.02.2026
BioGaia AB extends long-standing distribution partnership with Ewopharma
Citește mai mult
16.12.2025
Sugemalimab Achieves New Regulatory Milestone: European Commission Approves Stage Ⅲ NSCLC Indication
Citește mai mult
1
2
3
4
Următorul
![[Translate to Romania:]](/fileadmin/user_upload/Ewopharma_CStone_Sugemalimab_01.png "[Translate to Romania:]")
